Global Patient In-vivo Dosimetry (IVD) System Market Growth 2021-2026
According to this latest study, the 2021 growth of Patient In-vivo Dosimetry (IVD) System will have significant change from previous year. By the most conservative estimates of global Patient In-vivo Dosimetry (IVD) System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Patient In-vivo Dosimetry (IVD) System market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Patient In-vivo Dosimetry (IVD) System market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Portable
Fixed
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Medical
Scientific Research
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Landauer
Chiyoda Technol Corporation
Mirion Technologies
Thermo Fisher Scientific
Fuji Electric
Hitachi Aloka
Bertin Instruments
Tracerco
ATOMTEX
Panasonic
Polimaster
Renri
RadPro International GmbH
Ludlum Measurements
XZ LAB
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Patient In-vivo Dosimetry (IVD) System Consumption 2016-2026
2.1.2 Patient In-vivo Dosimetry (IVD) System Consumption CAGR by Region
2.2 Patient In-vivo Dosimetry (IVD) System Segment by Type
2.2.1 Portable
2.2.2 Fixed
2.3 Patient In-vivo Dosimetry (IVD) System Sales by Type
2.3.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
2.3.2 Global Patient In-vivo Dosimetry (IVD) System Revenue and Market Share by Type (2016-2021)
2.3.3 Global Patient In-vivo Dosimetry (IVD) System Sale Price by Type (2016-2021)
2.4 Patient In-vivo Dosimetry (IVD) System Segment by Application
2.4.1 Medical
2.4.2 Scientific Research
2.4.3 Others
2.5 Patient In-vivo Dosimetry (IVD) System Sales by Application
2.5.1 Global Patient In-vivo Dosimetry (IVD) System Sale Market Share by Application (2016-2021)
2.5.2 Global Patient In-vivo Dosimetry (IVD) System Revenue and Market Share by Application (2016-2021)
2.5.3 Global Patient In-vivo Dosimetry (IVD) System Sale Price by Application (2016-2021)
3 Global Patient In-vivo Dosimetry (IVD) System by Company
3.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Company
3.1.1 Global Patient In-vivo Dosimetry (IVD) System Sales by Company (2019-2021)
3.1.2 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Company (2019-2021)
3.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Company
3.2.1 Global Patient In-vivo Dosimetry (IVD) System Revenue by Company (2019-2021)
3.2.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Company (2019-2021)
3.3 Global Patient In-vivo Dosimetry (IVD) System Sale Price by Company
3.4 Global Manufacturers Patient In-vivo Dosimetry (IVD) System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Patient In-vivo Dosimetry (IVD) System Product Location Distribution
3.4.2 Players Patient In-vivo Dosimetry (IVD) System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Patient In-vivo Dosimetry (IVD) System by Region
4.1 Global Patient In-vivo Dosimetry (IVD) System by Region
4.1.1 Global Patient In-vivo Dosimetry (IVD) System Sales by Region
4.1.2 Global Patient In-vivo Dosimetry (IVD) System Revenue by Region
4.2 Americas Patient In-vivo Dosimetry (IVD) System Sales Growth
4.3 APAC Patient In-vivo Dosimetry (IVD) System Sales Growth
4.4 Europe Patient In-vivo Dosimetry (IVD) System Sales Growth
4.5 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Growth
5 Americas
5.1 Americas Patient In-vivo Dosimetry (IVD) System Sales by Country
5.1.1 Americas Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021)
5.1.2 Americas Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021)
5.2 Americas Patient In-vivo Dosimetry (IVD) System Sales by Type
5.3 Americas Patient In-vivo Dosimetry (IVD) System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Patient In-vivo Dosimetry (IVD) System Sales by Region
6.1.1 APAC Patient In-vivo Dosimetry (IVD) System Sales by Region (2016-2021)
6.1.2 APAC Patient In-vivo Dosimetry (IVD) System Revenue by Region (2016-2021)
6.2 APAC Patient In-vivo Dosimetry (IVD) System Sales by Type
6.3 APAC Patient In-vivo Dosimetry (IVD) System Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Patient In-vivo Dosimetry (IVD) System by Country
7.1.1 Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021)
7.1.2 Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021)
7.2 Europe Patient In-vivo Dosimetry (IVD) System Sales by Type
7.3 Europe Patient In-vivo Dosimetry (IVD) System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Patient In-vivo Dosimetry (IVD) System by Country
8.1.1 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021)
8.1.2 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021)
8.2 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Type
8.3 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Patient In-vivo Dosimetry (IVD) System Distributors
10.3 Patient In-vivo Dosimetry (IVD) System Customer
11 Global Patient In-vivo Dosimetry (IVD) System Market Forecast
11.1 Global Patient In-vivo Dosimetry (IVD) System Forecast by Region
11.1.1 Global Patient In-vivo Dosimetry (IVD) System Forecast by Regions (2021-2026)
11.2.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Patient In-vivo Dosimetry (IVD) System Forecast by Type
11.7 Global Patient In-vivo Dosimetry (IVD) System Forecast by Application
12 Key Players Analysis
12.1 Landauer
12.1.1 Landauer Company Information
12.1.2 Landauer Patient In-vivo Dosimetry (IVD) System Product Offered
12.1.3 Landauer Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Landauer Main Business Overview
12.1.5 Landauer Latest Developments
12.2 Chiyoda Technol Corporation
12.2.1 Chiyoda Technol Corporation Company Information
12.2.2 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product Offered
12.2.3 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Chiyoda Technol Corporation Main Business Overview
12.2.5 Chiyoda Technol Corporation Latest Developments
12.3 Mirion Technologies
12.3.1 Mirion Technologies Company Information
12.3.2 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product Offered
12.3.3 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Mirion Technologies Main Business Overview
12.3.5 Mirion Technologies Latest Developments
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Information
12.4.2 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product Offered
12.4.3 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Thermo Fisher Scientific Main Business Overview
12.4.5 Thermo Fisher Scientific Latest Developments
12.5 Fuji Electric
12.5.1 Fuji Electric Company Information
12.5.2 Fuji Electric Patient In-vivo Dosimetry (IVD) System Product Offered
12.5.3 Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Fuji Electric Main Business Overview
12.5.5 Fuji Electric Latest Developments
12.6 Hitachi Aloka
12.6.1 Hitachi Aloka Company Information
12.6.2 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product Offered
12.6.3 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Hitachi Aloka Main Business Overview
12.6.5 Hitachi Aloka Latest Developments
12.7 Bertin Instruments
12.7.1 Bertin Instruments Company Information
12.7.2 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product Offered
12.7.3 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Bertin Instruments Main Business Overview
12.7.5 Bertin Instruments Latest Developments
12.8 Tracerco
12.8.1 Tracerco Company Information
12.8.2 Tracerco Patient In-vivo Dosimetry (IVD) System Product Offered
12.8.3 Tracerco Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Tracerco Main Business Overview
12.8.5 Tracerco Latest Developments
12.9 ATOMTEX
12.9.1 ATOMTEX Company Information
12.9.2 ATOMTEX Patient In-vivo Dosimetry (IVD) System Product Offered
12.9.3 ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 ATOMTEX Main Business Overview
12.9.5 ATOMTEX Latest Developments
12.10 Panasonic
12.10.1 Panasonic Company Information
12.10.2 Panasonic Patient In-vivo Dosimetry (IVD) System Product Offered
12.10.3 Panasonic Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Panasonic Main Business Overview
12.10.5 Panasonic Latest Developments
12.11 Polimaster
12.11.1 Polimaster Company Information
12.11.2 Polimaster Patient In-vivo Dosimetry (IVD) System Product Offered
12.11.3 Polimaster Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Polimaster Main Business Overview
12.11.5 Polimaster Latest Developments
12.12 Renri
12.12.1 Renri Company Information
12.12.2 Renri Patient In-vivo Dosimetry (IVD) System Product Offered
12.12.3 Renri Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Renri Main Business Overview
12.12.5 Renri Latest Developments
12.13 RadPro International GmbH
12.13.1 RadPro International GmbH Company Information
12.13.2 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product Offered
12.13.3 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 RadPro International GmbH Main Business Overview
12.13.5 RadPro International GmbH Latest Developments
12.14 Ludlum Measurements
12.14.1 Ludlum Measurements Company Information
12.14.2 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product Offered
12.14.3 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Ludlum Measurements Main Business Overview
12.14.5 Ludlum Measurements Latest Developments
12.15 XZ LAB
12.15.1 XZ LAB Company Information
12.15.2 XZ LAB Patient In-vivo Dosimetry (IVD) System Product Offered
12.15.3 XZ LAB Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 XZ LAB Main Business Overview
12.15.5 XZ LAB Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Patient In-vivo Dosimetry (IVD) System Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Portable
Table 3. Major Players of Fixed
Table 4. Global Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2021) & (K Units)
Table 5. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
Table 6. Global Patient In-vivo Dosimetry (IVD) System Revenue by Type (2016-2021) & ($ million)
Table 7. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2016-2021)
Table 8. Global Patient In-vivo Dosimetry (IVD) System Sale Price by Type (2016-2021)
Table 9. Global Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2021) & (K Units)
Table 10. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
Table 11. Global Patient In-vivo Dosimetry (IVD) System Value by Application (2016-2021)
Table 12. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application (2016-2021)
Table 13. Global Patient In-vivo Dosimetry (IVD) System Sale Price by Application (2016-2021)
Table 14. Global Patient In-vivo Dosimetry (IVD) System Sales by Company (2019-2021) & (K Units)
Table 15. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Company (2019-2021)
Table 16. Global Patient In-vivo Dosimetry (IVD) System Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Company (2019-2021)
Table 18. Global Patient In-vivo Dosimetry (IVD) System Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Patient In-vivo Dosimetry (IVD) System Producing Area Distribution and Sales Area
Table 20. Players Patient In-vivo Dosimetry (IVD) System Products Offered
Table 21. Patient In-vivo Dosimetry (IVD) System Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Patient In-vivo Dosimetry (IVD) System Sales by Region (2016-2021) (K Units)
Table 25. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2016-2021)
Table 26. Global Patient In-vivo Dosimetry (IVD) System Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2016-2021)
Table 28. Americas Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021) & (K Units)
Table 29. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2016-2021)
Table 30. Americas Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2016-2021)
Table 32. Americas Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2021) & (K Units)
Table 33. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
Table 34. Americas Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2021) & (K Units)
Table 35. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
Table 36. APAC Patient In-vivo Dosimetry (IVD) System Sales by Region (2016-2021) & (K Units)
Table 37. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2016-2021)
Table 38. APAC Patient In-vivo Dosimetry (IVD) System Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2016-2021)
Table 40. APAC Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2021) & (K Units)
Table 41. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
Table 42. APAC Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2021) & (K Units)
Table 43. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
Table 44. Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021) & (K Units)
Table 45. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2016-2021)
Table 46. Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2016-2021)
Table 48. Europe Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2021) & (K Units)
Table 49. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
Table 50. Europe Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2021) & (K Units)
Table 51. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Patient In-vivo Dosimetry (IVD) System
Table 61. Key Application and Potential Industries of Patient In-vivo Dosimetry (IVD) System
Table 62. Key Challenges of Patient In-vivo Dosimetry (IVD) System
Table 63. Key Trends of Patient In-vivo Dosimetry (IVD) System
Table 64. Patient In-vivo Dosimetry (IVD) System Distributors List
Table 65. Patient In-vivo Dosimetry (IVD) System Customer List
Table 66. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Patient In-vivo Dosimetry (IVD) System Consumption Market Forecast by Region
Table 68. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Patient In-vivo Dosimetry (IVD) System Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Patient In-vivo Dosimetry (IVD) System Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Patient In-vivo Dosimetry (IVD) System Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Application (2021-2026)
Table 86. Landauer Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 87. Landauer Patient In-vivo Dosimetry (IVD) System Product Offered
Table 88. Landauer Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Landauer Main Business
Table 90. Landauer Latest Developments
Table 91. Chiyoda Technol Corporation Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 92. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product Offered
Table 93. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Chiyoda Technol Corporation Main Business
Table 95. Chiyoda Technol Corporation Latest Developments
Table 96. Mirion Technologies Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 97. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product Offered
Table 98. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. Mirion Technologies Main Business
Table 100. Mirion Technologies Latest Developments
Table 101. Thermo Fisher Scientific Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 102. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product Offered
Table 103. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Thermo Fisher Scientific Main Business
Table 105. Thermo Fisher Scientific Latest Developments
Table 106. Fuji Electric Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 107. Fuji Electric Patient In-vivo Dosimetry (IVD) System Product Offered
Table 108. Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Fuji Electric Main Business
Table 110. Fuji Electric Latest Developments
Table 111. Hitachi Aloka Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 112. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product Offered
Table 113. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Hitachi Aloka Main Business
Table 115. Hitachi Aloka Latest Developments
Table 116. Bertin Instruments Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 117. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product Offered
Table 118. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. Bertin Instruments Main Business
Table 120. Bertin Instruments Latest Developments
Table 121. Tracerco Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 122. Tracerco Patient In-vivo Dosimetry (IVD) System Product Offered
Table 123. Tracerco Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Tracerco Main Business
Table 125. Tracerco Latest Developments
Table 126. ATOMTEX Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 127. ATOMTEX Patient In-vivo Dosimetry (IVD) System Product Offered
Table 128. ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. ATOMTEX Main Business
Table 130. ATOMTEX Latest Developments
Table 131. Panasonic Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 132. Panasonic Patient In-vivo Dosimetry (IVD) System Product Offered
Table 133. Panasonic Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. Panasonic Main Business
Table 135. Panasonic Latest Developments
Table 136. Polimaster Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 137. Polimaster Patient In-vivo Dosimetry (IVD) System Product Offered
Table 138. Polimaster Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 139. Polimaster Main Business
Table 140. Polimaster Latest Developments
Table 141. Renri Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 142. Renri Patient In-vivo Dosimetry (IVD) System Product Offered
Table 143. Renri Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 144. Renri Main Business
Table 145. Renri Latest Developments
Table 146. RadPro International GmbH Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 147. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product Offered
Table 148. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 149. RadPro International GmbH Main Business
Table 150. RadPro International GmbH Latest Developments
Table 151. Ludlum Measurements Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 152. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product Offered
Table 153. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 154. Ludlum Measurements Main Business
Table 155. Ludlum Measurements Latest Developments
Table 156. XZ LAB Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors
Table 157. XZ LAB Patient In-vivo Dosimetry (IVD) System Product Offered
Table 158. XZ LAB Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 159. XZ LAB Main Business
Table 160. XZ LAB Latest Developments
List of Figures
Figure 1. Picture of Patient In-vivo Dosimetry (IVD) System
Figure 2. Patient In-vivo Dosimetry (IVD) System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Patient In-vivo Dosimetry (IVD) System Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Patient In-vivo Dosimetry (IVD) System Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Portable
Figure 10. Product Picture of Fixed
Figure 11. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type in 2020
Figure 12. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2016-2021)
Figure 13. Patient In-vivo Dosimetry (IVD) System Consumed in Medical
Figure 14. Global Patient In-vivo Dosimetry (IVD) System Market: Medical (2016-2021) & (K Units)
Figure 15. Patient In-vivo Dosimetry (IVD) System Consumed in Scientific Research
Figure 16. Global Patient In-vivo Dosimetry (IVD) System Market: Scientific Research (2016-2021) & (K Units)
Figure 17. Patient In-vivo Dosimetry (IVD) System Consumed in Others
Figure 18. Global Patient In-vivo Dosimetry (IVD) System Market: Others (2016-2021) & (K Units)
Figure 19. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
Figure 20. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application in 2020
Figure 21. Patient In-vivo Dosimetry (IVD) System Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Company in 2020
Figure 23. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Regions (2016-2021)
Figure 24. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region in 2020
Figure 25. Americas Patient In-vivo Dosimetry (IVD) System Sales 2016-2021 (K Units)
Figure 26. Americas Patient In-vivo Dosimetry (IVD) System Revenue 2016-2021 ($ Millions)
Figure 27. APAC Patient In-vivo Dosimetry (IVD) System Sales 2016-2021 (K Units)
Figure 28. APAC Patient In-vivo Dosimetry (IVD) System Revenue 2016-2021 ($ Millions)
Figure 29. Europe Patient In-vivo Dosimetry (IVD) System Sales 2016-2021 (K Units)
Figure 30. Europe Patient In-vivo Dosimetry (IVD) System Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue 2016-2021 ($ Millions)
Figure 33. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country in 2020
Figure 34. Americas Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country in 2020
Figure 35. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type in 2020
Figure 36. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application in 2020
Figure 37. United States Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region in 2020
Figure 42. APAC Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Regions in 2020
Figure 43. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type in 2020
Figure 44. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application in 2020
Figure 45. China Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country in 2020
Figure 52. Europe Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country in 2020
Figure 53. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type in 2020
Figure 54. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application in 2020
Figure 55. Germany Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application in 2020
Figure 64. Egypt Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Patient In-vivo Dosimetry (IVD) System Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
